AbbVie To Collaborate With Neomorph To Develop Molecular Glue Degraders For Oncology And Immunology | Markets Insider
(RTTNews) - AbbVie, Inc. (ABBV) and Neomorph, Inc. announced Thursday a collaboration and option-to-license agreement to develop novel molecular g...
Wall Street
2025-01-23
Comments
Share your comments